-
1
-
-
0037707889
-
Diagnosis and management of gestational hypertension and preeclampsia
-
DOI 10.1016/S0029-7844(03)00475-7
-
Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102: 181-192. (Pubitemid 36792143)
-
(2003)
Obstetrics and Gynecology
, vol.102
, Issue.1
, pp. 181-192
-
-
Sibai, B.M.1
-
2
-
-
3442901384
-
Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials
-
DOI 10.1016/j.ajog.2003.12.057, PII S000293780302177X
-
Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 2004; 190: 1520-1526. (Pubitemid 39006184)
-
(2004)
American Journal of Obstetrics and Gynecology
, vol.190
, Issue.6
, pp. 1520-1526
-
-
Sibai, B.M.1
-
4
-
-
2942750097
-
Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count
-
DOI 10.1097/01.AOG.0000126245.35811.2a
-
Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004; 103: 981-991. (Pubitemid 40459001)
-
(2004)
Obstetrics and Gynecology
, vol.103
, Issue.5
, pp. 981-991
-
-
Sibai, B.M.1
-
5
-
-
0034070780
-
Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?
-
Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol 2000; 182: 589-594. (Pubitemid 30207316)
-
(2000)
American Journal of Obstetrics and Gynecology
, vol.182
, Issue.3
, pp. 589-594
-
-
Stamilio, D.M.1
Sehdev, H.M.2
Morgan, M.A.3
Propert, K.4
Macones, G.A.5
-
6
-
-
50349085114
-
Expectant management of severe preeclampsia at less than 27 weeks' gestation: Maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management
-
Bombrys AE, Barton JR, Nowacki EA, et al. Expectant management of severe preeclampsia at less than 27 weeks' gestation: Maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol 2008; 199(247): e1-e6.
-
(2008)
Am J Obstet Gynecol
, vol.199
, Issue.247
-
-
Bombrys, A.E.1
Barton, J.R.2
Nowacki, E.A.3
-
7
-
-
10744227199
-
Circulating angiogenic factors and the risk of preeclampsia
-
DOI 10.1056/NEJMoa031884
-
Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683. (Pubitemid 38364626)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.7
, pp. 672-683
-
-
Levine, R.J.1
Maynard, S.E.2
Qian, C.3
Lim, K.-H.4
England, L.J.5
Yu, K.F.6
Schisterman, E.F.7
Thadhani, R.8
Sachs, B.P.9
Epstein, F.H.10
Sibai, B.M.11
Sukhatme, V.P.12
Karumanchi, S.A.13
-
8
-
-
37849021866
-
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
-
Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21: 9-23.
-
(2008)
J Matern Fetal Neonatal Med
, vol.21
, pp. 9-23
-
-
Romero, R.1
Nien, J.K.2
Espinoza, J.3
-
9
-
-
79551488222
-
Circulating angiogenic and antiangiogenic factors in women with eclampsia
-
Vaisbuch E, Whitty JE, Hassan SS, et al. Circulating angiogenic and antiangiogenic factors in women with eclampsia. Am J Obstet Gynecol 2011; 204(152): e1-e9.
-
(2011)
Am J Obstet Gynecol
, vol.204
, Issue.152
-
-
Vaisbuch, E.1
Whitty, J.E.2
Hassan, S.S.3
-
10
-
-
62549123349
-
Circulating angiogenic factors in gestational proteinuria without hypertension
-
Holston AM, Qian C, Yu KF, Epstein FH, Karumanchi SA, Levine RJ. Circulating angiogenic factors in gestational proteinuria without hypertension. Am J Obstet Gynecol 2009; 200(392): e1-e10.
-
(2009)
Am J Obstet Gynecol
, vol.200
, Issue.392
-
-
Holston, A.M.1
Qian, C.2
Yu, K.F.3
Epstein, F.H.4
Karumanchi, S.A.5
Levine, R.J.6
-
11
-
-
64249163613
-
Diagnosis and management of atypical preeclampsia-eclampsia
-
Sibai BM, Stella CL. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009; 200(481): e1-e7.
-
(2009)
Am J Obstet Gynecol
, vol.200
, Issue.481
-
-
Sibai, B.M.1
Stella, C.L.2
-
12
-
-
0037373006
-
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction hypertension, and proteinuria in preeclampsia
-
DOI 10.1172/JCI200317189
-
Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1(sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658. (Pubitemid 36278583)
-
(2003)
Journal of Clinical Investigation
, vol.111
, Issue.5
, pp. 649-658
-
-
Maynard, S.E.1
Min, J.-Y.2
Merchan, J.3
Lim, K.-H.4
Li, J.5
Mondal, S.6
Libermann, T.A.7
Morgan, J.P.8
Sellke, F.W.9
Stillman, I.E.10
Epstein, F.H.11
Sukhatme, V.P.12
Karumanchi, S.A.13
-
13
-
-
34249908643
-
Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia
-
DOI 10.1097/01.AOG.0000264552.85436.a1, PII 0000625020070600000016
-
Wikstrom AK, Larsson A, Eriksson UJ, Nash P, Norden-Lindeberg S, Olovsson M. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia. Obstet Gynecol 2007; 109: 1368-1374. (Pubitemid 46869876)
-
(2007)
Obstetrics and Gynecology
, vol.109
, Issue.6
, pp. 1368-1374
-
-
Wikstrom, A.-K.1
Larsson, A.2
Eriksson, U.J.3
Nash, P.4
Norden-Lindeberg, S.5
Olovsson, M.6
-
14
-
-
39549091069
-
VEGF and TGF-β are required for the maintenance of the choroid plexus and ependyma
-
DOI 10.1084/jem.20072041
-
Maharaj AS, Walshe TE, Saint-Geniez M, et al. VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med 2008; 205: 491-501. (Pubitemid 351281612)
-
(2008)
Journal of Experimental Medicine
, vol.205
, Issue.2
, pp. 491-501
-
-
Maharaj, A.S.R.1
Walshe, T.E.2
Saint-Geniez, M.3
Venkatesha, S.4
Maldonado, A.E.5
Himes, N.C.6
Matharu, K.S.7
Ananth Karumanchi, S.8
D'Amore, P.A.9
|